3-deoxyglucosone has been researched along with pyridoxal phosphate in 1 studies
| Studies (3-deoxyglucosone) | Trials (3-deoxyglucosone) | Recent Studies (post-2010) (3-deoxyglucosone) | Studies (pyridoxal phosphate) | Trials (pyridoxal phosphate) | Recent Studies (post-2010) (pyridoxal phosphate) |
|---|---|---|---|---|---|
| 186 | 8 | 77 | 6,511 | 140 | 860 |
| Protein | Taxonomy | 3-deoxyglucosone (IC50) | pyridoxal phosphate (IC50) |
|---|---|---|---|
| P2X purinoceptor 1 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, S; Niwa, T | 1 |
1 other study(ies) available for 3-deoxyglucosone and pyridoxal phosphate
| Article | Year |
|---|---|
Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage.
Topics: Animals; Deoxyglucose; Dialysis Solutions; Glycation End Products, Advanced; Hepatocyte Growth Factor; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Peritonitis; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2005 |